PFE vs TPR · P/E 20, rev $62.58B vs P/E 46, rev $8.00B
Pfizer Inc (PFE) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the PFE and TPR stock pages for the full models.
Not investment advice.